AKTX short interest
Akari Therapeutics Plc · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 14,529 |
|---|---|
| Change vs prior report | 3,766 (+35.0%) |
| Change over six months | +150.1% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 62,368 |
| Rank in Healthcare | #779 of 922 by days to cover |
AKTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 14,529 | +35.0% | 1.00 | 62,368 |
| 2026-09-15 | 10,763 | -64.3% | 1.00 | 101,607 |
| 2026-08-31 | 30,117 | -20.0% | 1.00 | 84,207 |
| 2026-08-14 | 37,660 | +38.0% | 1.00 | 42,080 |
| 2026-07-31 | 27,299 | +66.2% | 1.00 | 37,573 |
| 2026-07-15 | 16,430 | -8.7% | 1.00 | 71,381 |
| 2026-06-30 | 17,997 | -60.1% | 1.00 | 121,877 |
| 2026-06-15 | 45,077 | -62.9% | 1.00 | 88,099 |
| 2026-05-29 | 121,540 | +87.9% | 1.00 | 4,963,789 |
| 2026-05-15 | 64,685 | +300.9% | 1.80 | 35,844 |
| 2026-04-30 | 16,135 | +10.3% | 1.00 | 77,005 |
| 2026-04-15 | 14,622 | +151.7% | 1.00 | 45,393 |
| 2026-03-31 | 5,810 | -96.6% | 1.00 | 14,688 |
| 2026-03-13 | 168,708 | -19.4% | 1.00 | 330,160 |
| 2026-02-27 | 209,369 | -16.1% | 1.00 | 218,660 |
| 2026-02-13 | 249,671 | +4.2% | 1.43 | 174,372 |
| 2026-01-30 | 239,584 | +13.1% | 1.00 | 427,834 |
| 2026-01-15 | 211,849 | -51.1% | 1.00 | 375,479 |
| 2025-12-31 | 433,343 | -16.5% | 1.00 | 2,499,198 |
| 2025-12-15 | 519,225 | +650.6% | 1.00 | 2,333,715 |
| 2025-11-28 | 69,172 | -41.9% | 1.00 | 126,393 |
| 2025-11-14 | 119,117 | -14.1% | 1.00 | 799,466 |
| 2025-10-31 | 138,681 | -44.1% | 1.19 | 116,547 |
| 2025-10-15 | 247,961 | +66.7% | 2.15 | 115,446 |
| 2025-09-30 | 148,771 | +75.5% | 1.00 | 778,848 |
import finzdata as yf
yf.Ticker("AKTX").short_interest # every report since 2017
yf.Client().short_interest(["AKTX"], start="2018-01-01")Healthcare short interest · AKTX price history · Who owns AKTX · All short interest